Allison M. Deal
- Internal Medicine top 2%
- Aging top 5%
-
- Atrial Fibrillation Management and Outcomes 2
- Blood Pressure and Hypertension Studies 1
- Physiology top 10%
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 3
- Phytochemistry and Bioactive Compounds 1
-
- Cancer Treatment and Pharmacology 3
- Cancer survivorship and care 2
-
- Gold and Silver Nanoparticles Synthesis and Applications 1
-
- Single-cell and spatial transcriptomics 1
- Co-authors
- E. M. HawesRobert C. GosselinStephan MollJessica A. SorrentinoNorman E. SharplessJanakiraman KrishnamurthyChristin E. BurdDiego H. Castrillón
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Allison M. Deal
8 papers receiving 730 citations
Peers
Comparison fields: 5 of 84
- Internal Medicine 198
- Aging 47
- Cardiology and Cardiovascular Medicine 269
- Physiology 198
- Biomaterials 92
Countries citing papers authored by Allison M. Deal
This map shows the geographic impact of Allison M. Deal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison M. Deal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison M. Deal more than expected).
Fields of papers citing papers by Allison M. Deal
This network shows the impact of papers produced by Allison M. Deal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison M. Deal. The network helps show where Allison M. Deal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allison M. Deal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2020 | 98 | |
| 4 | 2017 | 1 | |
| 5 | 2016 | 14 | |
| 6 | 2014 | 13 | |
| 7 | 2014 | 94 | |
| 8 | 2014 | 9 | |
| 9 | 2013 | 305 | |
| 10 | 2013 | 202 |
About Allison M. Deal
Allison M. Deal is a scholar working on Biomaterials, Internal Medicine and Oncology, having authored 10 papers that have together received 736 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer survivorship and care (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Blood Pressure and Hypertension Studies (1 paper), Phytochemistry and Bioactive Compounds (1 paper), Gold and Silver Nanoparticles Synthesis and Applications (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Internal Medicine (198 citations), Aging (47 citations) and Cardiology and Cardiovascular Medicine (269 citations). Allison M. Deal has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include E. M. Hawes, Robert C. Gosselin, Stephan Moll, Jessica A. Sorrentino, Norman E. Sharpless, Janakiraman Krishnamurthy, Christin E. Burd, Diego H. Castrillón, David Beach and Nabeel Bardeesy. Their work appears in journals such as Cell, Cancer and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.